Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019: The Ivermectin in COVID Nineteen Study

BACKGROUND: Ivermectin was shown to inhibit severe acute respiratory syndrome coronavirus 2 replication in vitro, which has led to off-label use, but clinical efficacy has not been described previously. RESEARCH QUESTION: Does ivermectin benefit hospitalized coronavirus disease 2019 (COVID-19) patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajter, Juliana Cepelowicz, Sherman, Michael S., Fatteh, Naaz, Vogel, Fabio, Sacks, Jamie, Rajter, Jean-Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Inc under license from the American College of Chest Physicians. 2021
Materias:
Chest Infections: Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550891/
https://www.ncbi.nlm.nih.gov/pubmed/33065103
http://dx.doi.org/10.1016/j.chest.2020.10.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550891/
https://www.ncbi.nlm.nih.gov/pubmed/33065103
http://dx.doi.org/10.1016/j.chest.2020.10.009

Ejemplares similares